Optiray (Ioversol)

Ioversol, the active ingredient in Optiray, is a iodinated contrast agent presented as a injectable solution for intravenous use. It provides radiographic contrast enhancement for diagnostic imaging procedures.

GNH USA supplies Optiray as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, imaging centres and clinics worldwide.

Optiray (ioversol) is used in radiographic imaging procedures that require enhanced X‑ray attenuation.

Contrast‑enhanced CT: improved visualization of vascular structures and organ parenchyma Angiography: enhanced delineation of blood vessels during catheter‑based studies Urography: clear definition of urinary tract anatomy Myelography: better contrast of the spinal canal and nerve roots Cardiac imaging: enhanced coronary artery and cardiac chamber visualization

Adverse reactions may occur following administration of ioversol.

Common Side Effects: - Warm sensation at the injection site - Metallic taste in the mouth - Nausea - Vomiting - Mild headache - Transient flushing

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis) - Contrast‑induced nephropathy (renal toxicity) - Cardiovascular collapse - Pulmonary edema - Severe hypotension

Prior to using Optiray, clinicians should consider several safety measures.

Assess renal function: evaluate serum creatinine and eGFR before administration Screen for iodine allergy: obtain a detailed allergy history and consider pre‑medication if needed Hydration: ensure adequate patient hydration before and after the procedure Use lowest effective dose: tailor the volume to the specific imaging requirement Pregnancy considerations: avoid unless essential and discuss potential risks with the obstetric team Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake

Ioversol may interact with other agents that affect renal function or iodine handling.

Major Interactions (Avoid): - Concurrent nephrotoxic drugs: avoid or closely monitor renal function - High‑dose iodinated contrast agents: avoid cumulative iodine load

Moderate Interactions (Monitor Closely): - Metformin: suspend before and after the procedure in patients with impaired renal function - Beta‑blockers: may influence heart‑rate response during cardiac imaging - Thyroid medication: monitor thyroid function as iodine load can alter hormone levels